Saturday, April 08, 2006


hbv_research


hbv_research
... 23-Oct-2002 Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B; 23-Oct-2002 Hepatitis C ...

Lamivudine does not increase the efficacy of interferon in the ...
hbv_research archives Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. ...

Gastroenterology
Clinicopathological study of viral heaptitis, A. Malik IA, Muzaffar M & Aftab. Pakistan J Med Res 1987; 26(1): 4. AFIP, Rawalpindi ...

NewERListofDxCodes_Eff03 01 06 (2).xls
07022 VIRAL HEAPTITIS B WITH HEPATIC COMA CHRONIC WITHOUT MENTION OF H. 07023 VIRAL HEAPTITIS B WITH HEPATIC COMA CHRONIC WITH HEPATITIS DELTA ...

Lamivudine Journal Data
chronic Viral heaptitis B. Yang SS, Hsu CT, Hu JT, et al. World J Gastroenterol 2002 Oct;8(5):868-71 Abstract Remission of severe aplastic anemia associated ...

Cirrhosis Of The Liver (Interferon)


Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Immunization: National Immunization Awareness Month
Title: Immunization: National Immunization Awareness MonthCategory: Health FactsCreated: 8/1/2005Last Editorial Review: 8/1/2005

Herbal Components are Beneficial in Treating Cirrhosis
An Iranian research study recently concluded that the herbal components of Liv.52 are beneficial in the treatment of cirrhotic patients. The six-month study demonstrated that patients treated with Liv.52 showed better test results than those treated with placebo....

Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A InfectionCategory: Health NewsCreated: 7/13/2005 1:58:00 AMLast Editorial Review: 7/13/2005 1:58:14 AM

Friday, April 07, 2006


Regence BlueCross BlueShield of Oregon Regence BlueShield (PDF) (Interferon)


Regence BlueCross BlueShield of Oregon Regence BlueShield (PDF)
... Pegasys (peginterferon alfa-2a) and PegIntron (peginterferon alfa-2b) are pegylated forms ...

Pegasys Online, Description, Chemistry, Ingredients - Peginterferon alfa-2a - RxList Monographs
Description Monographs include chemistry, chemical structure, inactive ingredients ... Peginterferon alfa-2a. Company Issues Pacemaker Malfunction Warning ... Alpha interferons, including PEGASYS (peginterferon alfa 2a), may cause or aggravate fatal or life-threatening ...

Pegylated Interferon Therapy
... that the response to pegylated interferon peginterferon) alfa 2a plus ribavirin therapy for chronic ... standard interferon alfa 2a plus ribavirin therapy or peginterferon alfa 2a alone ...

Rough Draft of Advisory committee Briefing Package
... LaRoche Corporation submitted to FDA a License Application for PEGASYS (peginterferon alfa 2a) and COPEGUS ... for chronic hepatitis C. Peginterferon alfa 2b, both as monotherapy and in ...

Pegylated Interferon Therapy (PDF)
... alfa-2a and alfa-2b, respectively. Peginterferon alfa-2b. Peginterferon alfa-2b is a once-weekly interferon, indicated ...

Schering-Plough - News and Media - News Releases
Schering-Plough News and Media Section: latest News Releases, Fact Sheet, Management Team Profile, and Press Kit. ... Important new data on PEG-INTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination ... Exposure in Hepatitis C: Peginterferon Alfa-2b and Peginterferon Alfa-2a; M ...

Hepatitis C Treatment - Introduction: Chronic Hepatitis C - WrongDiagnosis.com


Introduction: Chronic Hepatitis C - WrongDiagnosis.com
Information on Chronic Hepatitis C as a medical condition with Chronic Hepatitis C information including symptoms, diagnosis, misdiagnosis, treatment, ...

Hepatitis C - pegylated interferons, ribavirin and alfa interferon ...
NICE has made the following recommendations about the use of interferon alfa, peginterferon alfa and ribavirin to treat chronic hepatitis C. ...

Management of Chronic Hepatitis C: Clinical Focus
How well do the results of initial liver biopsy predict measures of disease progression and outcomes of treatment in patients with chronic hepatitis C, ...

Hepatitis C Top Articles
Chronic hepatitis C Patients have the opportunity to enroll in a Phase 2 dose-ranging ... Chronic hepatitis C virus (HCV) infection affects approximately 3 ...

Hepatitis C Complete health information regarding HCV on ...
Once established, chronic hepatitis C virus infection causes an inflammation of the liver called chronic hepatitis. This condition can progress to scarring ...

Hepatitis C: Current Treatment
Patients with chronic hepatitis C should consult their doctors regarding possible ... The main goal of treatment of chronic hepatitis C is to eliminate ...

Wednesday, April 05, 2006


Management of Chronic Hepatitis C: Summary of Evidence Report ...


Management of Chronic Hepatitis C: Summary of Evidence Report ...
Chronic hepatitis C is often asymptomatic but may lead to cirrhosis of the ... The 10-year survival of those with chronic hepatitis C is approximately 50 ...

Hepatitis C: FAQ | CDC Viral Hepatitis
Can children receive interferon therapy for chronic hepatitis C? ... It is common for persons with chronic hepatitis C to have a liver enzyme level that ...

Hepatitis Central, Chronic Hepatitis Symptoms
Impairs Daily Functioning · Pruritis and the hepatitis C virus. Pruritis in chronic hepatitis C. (Itching). Ascites, Symptoms, Signs, and Diagnosis ...

Hepatitis C: Index | CDC Viral Hepatitis
Living with Chronic Hepatitis C. English Language version Abobe; Spanish Language version Abobe; Russian Language version Abobe. Hepatitis C Prevention ...

Management of Chronic Hepatitis C: Clinical Focus
How well do the results of initial liver biopsy predict measures of disease progression and outcomes of treatment in patients with chronic hepatitis C, ...

Hepatitis B and C -- familydoctor.org
What are chronic hepatitis B and chronic hepatitis C? *, How does a person get hepatitis B or C? *, What are the symptoms of acute hepatitis B or C? ...

Highlights of rising and falling U.S. stocks (Hepatitis C Treatment)


Highlights of rising and falling U.S. stocks
Investors Business Daily - Bally Total Fitness Holding ( BFT ) shares ended Tuesday's session with a 14.7% gain following a report that Virgin Group, run by billionaire Richard Branson, is mulling a takeover of the company. See full story. Shares of Corus Group Plc ( CGA

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Britain: Breast cancer patient s legal challenge highlights rationing
World Socialist Web Site - Ann Marie Rogers, a 54-year-old breast cancer patient and mother of two, went to the Court of Appeal this week as part of her fight to receive the drug Herceptin free of charge under the National Health Service (NHS). Last month, Rogers lost her

16-Year follow-up study reinforces Betaseron long-term efficacy
EurekAlert - San Diego, CA Berlex announced today that Betaseron (interferon beta 1b) remained consistently safe, effective and well tolerated over the long term, according to results of the Betaseron 16-Year Long-Term Follow-up (16-Year LTF) Study

Protein lab test could spot MS early
LabTechnologist.com - 15/03/2006 - A new laboratory method, which looks for a spinal fluid protein, may identify people with the earliest stages of multiple sclerosis (MS), greatly increasing the effectiveness of drug therapies to treat the 10,000 Americans, who are

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Friedman, Billings, Ramsey reiterated an "outperform" rating on Idenix Pharmaceuticals after Swiss pharmaceutical titan Novartis exercised an option to co-develop the biotech firm's lead drug candidate. Novartis (nyse: NVS - news - people ) will pay

Advocacy Groups Charge Schering-Plough With Racial Discrimination For
Medical News Today - Two advocacy groups last week said Schering-Plough is discriminating against black people by excluding them from the Phase II clinical trial of its new hepatitis C therapy, the Newark Star-Ledger reports. The trial includes 300 patients around the

Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate (Interferon)

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Tuesday, April 04, 2006


Interferon - Hepatitis C: The Test


Hepatitis C: The Test
Hepatitis C infection is the most common cause of chronic liver disease in North America; about 2% of all adults in the United States have been exposed to the virus, and 75-85% of those are

Hepatitis Information Network - HepNet
Frank Anderson, MD., FRCP(C) discusses hepatitis C: ''Side Effects'', ''Special Situations'', ''Special Symptoms and Their Management'', as well as ''Clinical Vignettes'' in Hepatitis Newsletters

Hepatitis C: Index | CDC Viral Hepatitis
Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV). You may be at risk for hepatitis C and should contact your medical care

Hepatitis C Manual
The Hepatitis C Council of NSW The Hepatitis C Council is an independent community based organisation. It provides a telephone information, support and referral service and produces and distributes

Deutsches Hepatitis C Forum e.V. - International Homepage
Informationen f r Betroffene, Angeh rige und auch rzte. Neben ausf hrlichen Darstellungen zur Erkrankung und Therapie stehen ausf hrliche Berichte Betroffener zur Verf gung. Ein bundesweiter

Hepatitis C Treatment Project
Hepatitis C website offering information, long-distance treatment project, homeopathic approach and research details.